Condensed Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Gross sales	$ 90,829	$ 0
Discounts and allowances	(40,511)
Net sales	50,318	0
Cost of sales	6,357	0
Gross profit	43,961	0
Operating expenses:
Selling and marketing	189,323
Research and development	1,054,310	2,497,218
General and administrative	3,715,340	2,622,945
Depreciation and amortization of intangible assets	83,486	97,113
Restructuring charges	0	726,280
Total operating expenses	5,042,459	5,943,556
Loss from operations	(4,998,498)	(5,943,556)
Other income (expense):
Other income	44,798	68,772
Interest expense	(29,466)	(853,805)
Amortization of debt discount	(19,549)	(35,513)
Loss on forward purchase agreement	(5,700,451)	(10,268,130)
Loss on lease termination	(44,577)	0
Change in fair value of derivative liabilities	0	826,980
Total other income (expense)	(5,749,245)	(10,261,696)
Loss from continuing operations before income taxes	(10,747,743)	(16,205,252)
Income tax benefit	(97,279)	0
Loss from continuing operations	(10,650,464)	(16,205,252)
(Loss) income from discontinued operations, net of tax	(1,152,276)	760,165
Gain on sale of discontinued operations attributable to common shareholders	1,434,479	0
Net loss	(10,368,261)	(15,445,087)
Dividends on Legacy Series A, Legacy Series C-1, and Legacy C-2 preferred stock	0	(676,023)
Net loss attributable to common stockholders	$ (10,368,261)	$ (16,121,110)
Basic
Net loss from continuing operations - basic	$ (0.50)	$ (1.53)
Discontinued operations, net of tax - basic	0.01	0.07
Net loss per common share - basic	(0.49)	(1.46)
Diluted
Net loss from continuing operations - diluted	(0.50)	(1.53)
Discontinued operations, net of tax - diluted	0.01	0.07
Net loss per common share - diluted	$ (0.49)	$ (1.46)
Weighted average of shares outstanding , Basic	21,362,735	11,021,167
Weighted average of shares outstanding , Diluted	21,362,735	11,021,167